SUMO2/3 Produkte
(Small Ubiquitin Related Modifier 2/3 (SUMO2/3))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene SUMO2/3 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
WB, IF, ELISA, IHC (fro)
Validierungen
- (1)
- (7)
Kat. Nr.
ABIN2452139
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
WB, IF, ELISA, IHC
Validierungen
- (14)
Kat. Nr.
ABIN3032650
Menge
0.4 mL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IF, IHC (p)
Validierungen
- (2)
- (3)
Kat. Nr.
ABIN1882138
Menge
400 μL
Datenblatt
Datenblatt
Empfohlene SUMO2/3 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
Kat. Nr.
ABIN6232502
Menge
96 tests
Datenblatt
Datenblatt
Neueste Publikationen zu unseren SUMO2/3 Produkten
: "Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains." in: Journal of virology, Vol. 89, Issue 20, pp. 10260-72, (2015) (PubMed).: "Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus." in: Nature immunology, Vol. 14, Issue 8, pp. 804-11, (2013) (PubMed).
: "PKC? mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation." in: The Journal of cell biology, Vol. 193, Issue 5, pp. 867-84, (2011) (PubMed).
: "Lysine deacetylation in ischaemic preconditioning: the role of SIRT1." in: Cardiovascular research, Vol. 89, Issue 3, pp. 643-9, (2011) (PubMed).
: "Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation." in: The Journal of biological chemistry, Vol. 286, Issue 3, pp. 2273-84, (2011) (PubMed).
: "Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress." in: Disease models & mechanisms, Vol. 3, Issue 9-10, pp. 595-604, (2010) (PubMed).
: "Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity." in: Molecular and cellular biology, Vol. 28, Issue 8, pp. 2771-81, (2008) (PubMed).
: "Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation." in: Oncogene, Vol. 26, Issue 3, pp. 395-406, (2007) (PubMed).
: "Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation." in: The Journal of biological chemistry, Vol. 281, Issue 32, pp. 23180-90, (2006) (PubMed).
: "SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity." in: The Journal of biological chemistry, Vol. 280, Issue 26, pp. 24330-8, (2005) (PubMed).
Synonyme und alternative Namen zu SUMO2/3
small ubiquitin-like modifier 2 (SUMO2), SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae)-like (LOC711990), small ubiquitin-related modifier 2 (LOC714892), SUMO2Bezeichner auf Proteinebene für SUMO2/3
- SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae)
- small ubiquitin-related modifier 2
Sie sind hier:
